-
Gates Foundation Backs Takeda Polio Vaccine With $38 Million Grant
Japan's Takeda Pharmaceuticals is to get $38 million from the Bill & Melinda Gates Foundation to develop a crucial, low-cost polio vaccine for use in developing countries.
- Categories
- Health Care
- Tags
- vaccines
-
Charity Urges Price Cut for Pneumonia Vaccine for Poor Children
Global charity Medecins Sans Frontieres delivered a petition with hundreds of thousands of signatures to pharmaceutical giant Pfizer Inc on Wednesday, asking the drugmaker to slash the price of its pneumonia vaccine for poor children.
- Categories
- Health Care
- Tags
- vaccines
-
Closing the Gap on Vaccine Efficacy in the ‘Global South’
Vaccines and antibiotics occupy a privileged position in the history of medicine. They are humanity’s “magic bullets” — categories of intervention so effective and easy to deliver that they have the capacity to single-handedly eradicate entire diseases from human history. But just as the heady utopia of an antibiotic age has given way to the cold, evolutionary reality of antibiotic resistance, we must now also confront the pervasive problem of vaccine failure in the global South.
- Categories
- Health Care
- Region
- South Asia
- Tags
- vaccines
-
Inside the High-Stakes World of Vaccine Development
Vaccines are widely recognized as the most effective way we’ve got to fight infectious disease, a bulwark against a staggeringly diverse array of potentially pathogenic organisms looking to circumvent our defenses. Pervasive vaccines like those for influenza, measles, or polio offer a sense of security, but it wasn’t always so, and a range of established and emerging threats continue to present real problems. Given the physical interconnectedness of even the most remote locations with the rest of the world, esoteric pathogens have a fast track to global transmission like never before.
- Categories
- Health Care
- Tags
- vaccines
-
The Quest for a Malaria Vaccine Continues
The 2016 World Malaria Report estimates that there were approximately 215 million cases of malaria and 438,000 deaths in 2015. The majority of deaths occur in sub-Saharan Africa and among young children, and malaria remains endemic in around 100 countries with over three billion people at risk. Over the past 15 years there have been major gains in reducing the global burden of malaria; however, it continues to be a major cause of mortality and morbidity globally. The 25th of April marks World Malaria Day, highlighting key issues in the fight against this major disease. Plasmodium falciparum causes the bulk of malaria, with P. vivax being a second major cause. World Malaria Day 2016 highlights the need for innovation to develop effective vaccines, new drugs, and better diagnostics to ensure continued success towards malaria elimination.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
Nigeria: Vaccine Bill to Hit U.S. $345 Million as Donor Support Vanishes
The National Primary Health Care Development Agency (NPHCDA) says government spending on immunisation is expected to top $345 million a year by 2022 when international funding support from the Global Alliance for Vaccine Initiative (GAVI) is completely withdrawn.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
J&J Ebola Vaccine Has Promise as Wider Test Awaits Next Outbreak
An experimental Ebola vaccine from Johnson & Johnson, boosted by a second immunization shot from biotechnology company Bavarian Nordic A/S, generated a powerful immune response among volunteers in its first tests in humans.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
The Entire World Has 2 Weeks to Switch Over to a New Oral Polio Vaccine. Here’s Why.
The world is closer than ever to eradicating polio, the horrible disease that inflicts paralysis on its primarily young victims. It's not far-fetched to say that very soon the world will see its last polio case.
- Categories
- Health Care
- Tags
- vaccines